Answers are grounded in this paper and cite their sources.
The use of oncological treatment was below recommendations in guidelines but increased during the study period. Treatment was given predominantly to men with c/pN2-3 and M1-disease. Survival was higher among men treated with curative intent; this could be due to patient selection bias.
No takes yet. Share an insight, caveat, or question.
Ulvskog et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: